Videos

Delving Into Clinical Research For Patients With Breast Cancer

February 26th 2025, 4:12pm

Video

Dr. Yuan Yuan breaks down studies for patients with breast cancer, such as the phase 3 CompassHER2 RD Trial.

Clinical Trials to Watch in Triple-Negative Breast Cancer

February 26th 2025, 4:03pm

Video

An expert shares information on a pair of noteworthy active trials in breast cancer that patients should be aware of.

Understanding Biliary Tract Cancer and The Current Standard of Care

February 25th 2025, 5:00pm

Video

An expert explains what biliary tract cancers are and the current landscape of treatment as well as future advancements.

What Patients With Cancer Should Know About DPD Deficiency Prior to Chemo

February 24th 2025, 10:00pm

Video

Dr. Gabriel A. Brooks discusses what DPD deficiency is and why it is important for patients with cancer receiving 5-FU or Xeloda to be aware of it.

GAP Triplet May Be Less Safe Than Doublet Chemo in Biliary Tract Cancer

February 24th 2025, 5:00pm

Video

An expert explains that the GAP regimen did not improve overall survival in advanced biliary tract cancer versus the doublet and increased severe side effects.

COSMIC-313 Trial Lead Breaks Down Treatment Intensification in RCC

February 23rd 2025, 3:00pm

Video

Dr. Laurence Albiges discusses triplet therapies, highlighting which patients with RCC may garner the most benefit with this treatment intensification.

Personalized Medicine Makes Strides Across the GU Oncology Treatment Space

February 22nd 2025, 3:00pm

Video

Dr. Chandler Park discusses the importance of genetic testing and personalized care in patients with genitourinary cancers.

The Importance of Genetic Testing in Metastatic Colorectal Cancer

February 21st 2025, 10:00pm

Video

An expert explains the importance of genetic testing in metastatic colorectal cancer, as recent FDA approval highlights its role in guiding targeted treatments.

Personalized Cancer Vaccine Demonstrates Responses in Kidney Cancer

February 20th 2025, 5:00pm

Video

Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a vaccine.

Krazati and Erbitux Combo Benefits KRAS G12C+ Metastatic Colorectal Cancer

February 20th 2025, 4:00pm

Video

Dr. Nataliya Uboha explained the benefit of treatment with Krazati combined with Erbitux in KRAS G12C–mutant metastatic colorectal cancer.